Considerations for future studies on the effect of late phase oxygen strategies on retinopathy of prematurity

Charlotte M Nusman1, Nicoline E Schalij-Delfos2, Rolf H H Groenwold3,4

  • 1Department of Neonatology, Emma Children's Hospital, Amsterdam University Medical Centers, Amsterdam, Netherlands.

Frontiers in Pediatrics
|November 10, 2022
PubMed

Insights

Higher oxygen saturation and hemoglobin levels may prevent retinopathy of prematurity (ROP) treatment in premature infants. However, large studies are needed to confirm effectiveness, questioning the feasibility of future randomized controlled trials.

Area of Science:

  • Neonatal ophthalmology
  • Perinatal medicine
  • Retinopathy of prematurity research

Background:

  • Retinopathy of prematurity (ROP) is a leading cause of blindness in premature infants.
  • Current strategies focus on managing oxygenation, but optimal levels remain debated.
  • High intraocular oxygen delivery is hypothesized to protect the developing retina.

Purpose of the Study:

  • To review evidence for strategies increasing intraocular oxygen delivery in premature infants.
  • To evaluate interventions like higher saturation targets and hemoglobin levels for ROP prevention.
  • To discuss the potential for future research, including randomized controlled trials.

Main Methods:

  • Literature review of current evidence on oxygenation strategies in preterm neonates.
  • Analysis of studies examining higher hemoglobin and saturation targets.
  • Discussion of the limitations and requirements for future research designs.

Main Results:

  • Evidence suggests higher saturation targets and hemoglobin levels may be beneficial for preventing ROP.
  • The current evidence base is limited, necessitating further investigation.
  • Significant challenges exist in designing and conducting large-scale trials in this population.

Conclusions:

  • Strategies to enhance intraocular oxygen delivery warrant further investigation for ROP prevention.
  • The feasibility of conducting large randomized controlled trials is a significant concern.
  • Future research should carefully consider sample size and design to yield conclusive results.